The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
TBC Janssen-Cilag Pty Ltd
Product name
TBC
Sponsor
Accepted date
May-2024
Active ingredients
daratumumab
Proposed indication
For the treatment of patients with newly diagnosed multiple myeloma.
Application type
C (new indication)
Publication date
May-2024